Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Brain tumor Stories

2014-01-11 23:02:39

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org, discussing new research that has found a mechanism implicated in brain cancer and a drug that is proving to decrease brain tumor growth. New York, NY (PRWEB) January 11, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org on January 1, 2014, that...

2014-01-10 23:22:56

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Bennett Nester, a 3-year old brain tumor patient who is focusing on bringing joy to others despite his own battle with the terrible disease. New York, NY (PRWEB) January 10, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Bennett Nester, a 3-year-old brain tumor patient whose efforts are bringing joy to children that are...

2014-01-09 16:25:42

Highlights Include ICT-107 Results to Date, Ongoing Data Analyses and Phase III Planning LOS ANGELES, Jan. 9, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today issued the following letter to shareholders providing an update on the Company's ICT-107 clinical program in patients with newly diagnosed glioblastoma (GBM). (Logo: http://photos.prnewswire.com/prnh/20140109/AQ43875LOGO) To Our Shareholders: Since the December 11, 2013 announcement of...

2014-01-08 12:31:02

2014 procedures expected to increase 31% over 8-year total as intraoperative MRI utilization expands to improve outcomes in growing number of neurosurgical applications MINNEAPOLIS, Jan. 8, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that an internal study of 40 worldwide VISIUS(®) Surgical Theatre hospital customers indicates that nearly 13,000 patients have been treated using intraoperative MRI (iMRI) since the first...

2014-01-07 08:32:13

HEIDELBERG, Germany, Jan. 7, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will present the results of the completed phase II efficacy trial in patients with recurrent glioblastoma at the Biotech Showcase(TM) in San Francisco. The presentation will take place on Tuesday, Jan. 14, at 4 p.m. PST at the Parc 55 Wyndham San Francisco - Union Square. "The results of this controlled phase II...

2014-01-04 23:25:06

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Western Australian Sutherlan Scudds for his undeniable strength and will to beat brain cancer. New York, NY (PRWEB) January 03, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, praises Australian national fencing champion, Sutherlan Scudds, for his positive outlook on his brain cancer diagnosis and treatment. According to a January 1st,...

2014-01-04 23:02:32

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that discusses a new brain cancer treatment that will specifically target glioblastomas. New York, NY (PRWEB) January 04, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that takes a deeper look into a new brain cancer treatment that will...

2013-12-30 08:26:17

First European Patient In Trial Operated On In June, Profiled In BBC Report BETHESDA, Md., Dec. 30, 2013 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma...

2013-12-28 23:02:56

In response to an article published by KFor.com, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a minimally intrusive brain surgery that was proven to be successful for an Oklahoma City brain cancer patient. New York, NY (PRWEB) December 28, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by KFor.com on December 17th, which discusses a new...

2013-12-27 23:04:45

In response to an article published by Medical News Today (MNT), Voices Against Brain Cancer discusses a new brain tumor vaccine that is personalized to each patient. New York, NY (PRWEB) December 27, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Medical News Today that discusses a new brain cancer vaccine called HSPPC-96, which is personally molded to each patient’s genetic makeup. According to the...